Packaging Alliance Brings Aseptic Filling Solutions to Market

Suppliers of aseptic filling and packaging equipment announced the creation of the Matrix Alliance in a Feb. 16, 2016 press release. The group’s mission is to bring to market complete solutions for aseptic filling to accelerate the adoption rate of breakthrough medicines.

The Alliance was formed at the initiative of Vanrx Pharmasystems, a machinery supplier that uses isolated robotics and machine vision to automate the packaging of injectable drugs. Inaugural members include ARaymond Life (a GMP EU pharmaceutical establishment specializing in plastic injection and fasteners), Daikyo Seiko (a manufacturer of pharmaceutical packaging and medical device components), Datwyler Group (a manufacturer of components for injectable packaging and drug delivery systems), Ompi (a manufacturer of glass pharmaceutical primary packaging), Schott AG (which specializes in glass and glass ceramics), Schott Kaisha (a manufacturer of tubular glass primary packaging in India), and SiO2 Medical Products ( a manufacturer of coated plastic vials, prefilled syringes, and cartridges ). As part of the collaboration, members will leverage the testing and certification of their combined offerings. The Alliance will also serve as a forum to provide strategic direction, education, and awareness of new aseptic packaging solutions within the membership and to the market.

The companies are collectively focused on pharmaceutical manufacturing and packaging technologies, and plan to concentrate on four key areas:

• Testing new, presterilized container and nested closure systems for parenteral (injectable) medicines

• Ensuring the compatibility of components from different members

• Driving industry awareness of those solutions

• Collaborating on industry education regarding new medicine packaging solutions.

“The need for collaboration in this area arises from the increasing sophistication of manufacturing processes and packaging needed for next-generation parenteral pharmaceuticals,” said Alliance members in a joint press release statement. “Emerging categories of complex, high-value injectable drugs share the need for innovation in fill/finish and packaging. We believe that collaboration will speed the path of new therapies to the market by our customers, the pharmaceutical companies.”

Source: Vanrx Pharmasystems